Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncology

In canine and feline populations, the number of neoplasm cases continues to increase around the world. Attempts are being made in centres of research to identify new biomarkers that speed up and improve the quality of oncological diagnostics and therapy in human and animal tumour patients. Cyclooxyg...

Full description

Bibliographic Details
Main Authors: Szweda Marta, Rychlik Andrzej, Babińska Izabella, Pomianowski Andrzej
Format: Article
Language:English
Published: Sciendo 2020-03-01
Series:Journal of Veterinary Research
Subjects:
Online Access:https://doi.org/10.2478/jvetres-2020-0018
_version_ 1818460269866647552
author Szweda Marta
Rychlik Andrzej
Babińska Izabella
Pomianowski Andrzej
author_facet Szweda Marta
Rychlik Andrzej
Babińska Izabella
Pomianowski Andrzej
author_sort Szweda Marta
collection DOAJ
description In canine and feline populations, the number of neoplasm cases continues to increase around the world. Attempts are being made in centres of research to identify new biomarkers that speed up and improve the quality of oncological diagnostics and therapy in human and animal tumour patients. Cyclooxygenase-2 (COX-2) is a promising biomarker with increasing relevance to human oncology, but as yet with less application in veterinary oncology. The expression of COX-2 increases significantly during pathological processes involving inflammation, pain or fever. It is also overexpressed in humans presenting various types of tumours and in selected types of tumours in animals, particularly in dogs. This article discusses the expression of COX-2 in canine and feline tumours, the importance of COX-2 as a biomarker with diagnostic, therapeutic, prognostic and predictive relevance in oncology, and the clinical significance of inhibiting COX-2 overexpression in tumours.
first_indexed 2024-12-14T23:27:34Z
format Article
id doaj.art-069126e8849f4e33936e7a6381c31749
institution Directory Open Access Journal
issn 2450-8608
language English
last_indexed 2024-12-14T23:27:34Z
publishDate 2020-03-01
publisher Sciendo
record_format Article
series Journal of Veterinary Research
spelling doaj.art-069126e8849f4e33936e7a6381c317492022-12-21T22:43:46ZengSciendoJournal of Veterinary Research2450-86082020-03-0164115116010.2478/jvetres-2020-0018jvetres-2020-0018Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncologySzweda Marta0Rychlik Andrzej1Babińska Izabella2Pomianowski Andrzej3Department of Internal Diseases with Clinic, 10-719Olsztyn, PolandDepartment of Clinical Diagnostics, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-719Olsztyn, PolandDepartment of Pathophysiology, Forensic Medicine and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-718Olsztyn, PolandDepartment of Internal Diseases with Clinic, 10-719Olsztyn, PolandIn canine and feline populations, the number of neoplasm cases continues to increase around the world. Attempts are being made in centres of research to identify new biomarkers that speed up and improve the quality of oncological diagnostics and therapy in human and animal tumour patients. Cyclooxygenase-2 (COX-2) is a promising biomarker with increasing relevance to human oncology, but as yet with less application in veterinary oncology. The expression of COX-2 increases significantly during pathological processes involving inflammation, pain or fever. It is also overexpressed in humans presenting various types of tumours and in selected types of tumours in animals, particularly in dogs. This article discusses the expression of COX-2 in canine and feline tumours, the importance of COX-2 as a biomarker with diagnostic, therapeutic, prognostic and predictive relevance in oncology, and the clinical significance of inhibiting COX-2 overexpression in tumours.https://doi.org/10.2478/jvetres-2020-0018dogcatbiomarkercox-2tumours
spellingShingle Szweda Marta
Rychlik Andrzej
Babińska Izabella
Pomianowski Andrzej
Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncology
Journal of Veterinary Research
dog
cat
biomarker
cox-2
tumours
title Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncology
title_full Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncology
title_fullStr Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncology
title_full_unstemmed Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncology
title_short Cyclooxygenase-2 as a biomarker with diagnostic, therapeutic, prognostic, and predictive relevance in small animal oncology
title_sort cyclooxygenase 2 as a biomarker with diagnostic therapeutic prognostic and predictive relevance in small animal oncology
topic dog
cat
biomarker
cox-2
tumours
url https://doi.org/10.2478/jvetres-2020-0018
work_keys_str_mv AT szwedamarta cyclooxygenase2asabiomarkerwithdiagnostictherapeuticprognosticandpredictiverelevanceinsmallanimaloncology
AT rychlikandrzej cyclooxygenase2asabiomarkerwithdiagnostictherapeuticprognosticandpredictiverelevanceinsmallanimaloncology
AT babinskaizabella cyclooxygenase2asabiomarkerwithdiagnostictherapeuticprognosticandpredictiverelevanceinsmallanimaloncology
AT pomianowskiandrzej cyclooxygenase2asabiomarkerwithdiagnostictherapeuticprognosticandpredictiverelevanceinsmallanimaloncology